Literature DB >> 16585171

Carcinogenic Cr(VI) and the nutritional supplement Cr(III) induce DNA deletions in yeast and mice.

Zhanna Kirpnick-Sobol1, Ramune Reliene, Robert H Schiestl.   

Abstract

Industrial Cr(VI) emissions contaminate drinking water sources across the U.S., and many people take Cr(III) nutritional supplements. Cr(VI) is a human pulmonary carcinogen, but whether it is carcinogenic in the drinking water is not known. Due to widespread human exposure, it is imperative to determine the carcinogenic potential of Cr(VI) and Cr(III). DNA deletions and other genome rearrangements are involved in carcinogenesis. We determined the effects of Cr(VI) as potassium dichromate and Cr(III) as chromium(III) chloride on the frequencies of DNA deletions measured with the deletion assay in Saccharomyces cerevisiae and the in vivo p(un) reversion assay in C57BL/6J p(un)/p(un) mice. Exposing yeast and mice via drinking water to Cr(VI) and Cr(III) significantly increased the frequency of DNA deletions. We quantified intracellular chromium concentrations in yeast and tissue chromium concentrations in mice after exposure. Surprisingly, this revealed that Cr(III) is a more potent inducer of DNA deletions than Cr(VI) once Cr(III) is absorbed. This study concludes that both the environmental contaminant Cr(VI) and the nutritional supplement Cr(III) increase DNA deletions in vitro and in vivo, when ingested via drinking water.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16585171     DOI: 10.1158/0008-5472.CAN-05-3944

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Chromium-VI arrests cell cycle and decreases granulosa cell proliferation by down-regulating cyclin-dependent kinases (CDK) and cyclins and up-regulating CDK-inhibitors.

Authors:  Jone A Stanley; JeHoon Lee; Thamizh K Nithy; Joe A Arosh; Robert C Burghardt; Sakhila K Banu
Journal:  Reprod Toxicol       Date:  2011-05-20       Impact factor: 3.143

2.  Iodide-assisted silver nanoplates for colorimetric determination of chromium(III) and copper(II) via an aggregation/fusion/oxidation etching strategy.

Authors:  Ziyi Wang; Yuexiang Lu; Jiawei Pang; Jingwei Sun; Fengyi Yang; Hui Li; Yueying Liu
Journal:  Mikrochim Acta       Date:  2019-12-05       Impact factor: 5.833

3.  Hexavalent chromium-induced apoptosis of granulosa cells involves selective sub-cellular translocation of Bcl-2 members, ERK1/2 and p53.

Authors:  Sakhila K Banu; Jone A Stanley; Jehoon Lee; Sam D Stephen; Joe A Arosh; Patricia B Hoyer; Robert C Burghardt
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-22       Impact factor: 4.219

4.  Cobalt-chromium toxic retinopathy case study.

Authors:  Warren Apel; Denis Stark; Anthony Stark; Stephen O'Hagan; Joseph Ling
Journal:  Doc Ophthalmol       Date:  2012-12-15       Impact factor: 2.379

5.  Actin-mediated endocytosis limits intracellular Cr accumulation and Cr toxicity during chromate stress.

Authors:  Sara L Holland; Simon V Avery
Journal:  Toxicol Sci       Date:  2009-07-23       Impact factor: 4.849

6.  Postnatal exposure to chromium through mother's milk accelerates follicular atresia in F1 offspring through increased oxidative stress and depletion of antioxidant enzymes.

Authors:  Jone A Stanley; Kirthiram K Sivakumar; Thamizh K Nithy; Joe A Arosh; Patricia B Hoyer; Robert C Burghardt; Sakhila K Banu
Journal:  Free Radic Biol Med       Date:  2013-03-05       Impact factor: 7.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.